Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ryu Niinaga"'
Autor:
Hiroyasu Yamamoto, Hiromi Uekita, Manami Yoshii, Ryu Niinaga, Noriko Yamane, Shinji Kihara, Keiko Yamauchi-Takihara
Publikováno v:
Clinica chimica acta; international journal of clinical chemistry. 516
Background Mac-2 binding protein (Mac-2BP) is used as a serum biomarker of nonalcoholic steatohepatitis, considered to be a liver phenotype of metabolic syndrome (MetS). In this study, we investigated the serum Mac-2BP concentrations-correlated MetS-
Autor:
Nana Kuroda, Iichiro Shimomura, Ikoi Kochi, Hiroyasu Yamamoto, Akane Matsumoto, Shinji Kihara, Tohru Funahashi, Hiromi Uekita, Ryu Niinaga
Publikováno v:
Biochemical and Biophysical Research Communications. 470:425-430
Background Adiponectin (APN) is an adipocyte-derived bioactive molecule with anti-diabetic and anti-atherogenic properties. Although anti-diabetic effects are mostly mediated by the adiponectin receptors AdipoR1 and AdipoR2, the anti-atherogenic mech
Autor:
Tetsuro Matsuoka, Manami Yoshii, Hiroyasu Yamamoto, Hiromi Uekita, Ryu Niinaga, Akane Matsumoto, Noriko Yamane, Ikoi Kochi, Shinji Kihara
Publikováno v:
Atherosclerosis. 253
Background and aims Adiponectin (APN) is an adipocyte-derived bioactive molecule with anti-diabetic and anti-atherogenic properties. Although the anti-diabetic effects of APN are mediated by AdipoR1 and AdipoR2, the anti-atherogenic mechanisms of APN